Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJade Road Inv Regulatory News (JADE)

  • There is currently no data for JADE

US Dollar-denominated Corporate Bonds

1 Dec 2022 11:19

RNS Number : 2721I
Jade Road Investments Limited
01 December 2022
 

1 December 2022

JADE ROAD INVESTMENTS LIMITED

("Jade Road Investments", "JADE", the "Company" or the "Group")

 

Jade Road Investments Limited (AIM: JADE), the London quoted pan-Asian diversified investment vehicle focused on providing shareholders with attractive uncorrelated, risk-adjusted long-term returns provides the following update concerning its US Dollar-denominated secured debt, issued as loan notes with a 12.5% coupon ("Loan Notes").

 

Further to discussions with all Loan Note holders ("Noteholders"), the Company has agreed the following changes to the structure of the Notes with Noteholders:

• extended maturity of the Loan Notes issued to 31 December 2023;

• increased the interest rate payable on the principal amount of the Loan Notes outstanding to 15% per annum from the date of the Supplemental Instrument;

• increased the interest rate payable on the principal amount of the outstanding Loan Notes to 16% per annum where US$1,800,000 or more of the principal amount of the Loan Notes remains outstanding by 30 June 2023; 

• a "priority return" provision requiring the Company to utilise proceeds received by it pursuant to an equity placing of more than £10,000,000 ("Qualifying Placing") or sale of any company, body corporate, asset, instrument, or undertaking (including any contractual rights) within the Company's existing portfolio ("Asset Sale") in making repayment on the Notes. Any such repayment would be limited to 10% of the net proceeds received by the Company pursuant to a Qualifying Placing, or 65% of the net proceeds received by the Company pursuant to an Asset Sale; and

• warrants: Loan Note holders will be issued with 3-year warrants equivalent to 5% of the next share issuance undertaken by the Company with a strike price which is a 50% premium to the price of such share issuance.

The Company has received the required formal consent of Noteholders to these terms and accordingly has today executed a supplemental loan note instrument and warrant instrument.

 

 

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Jade Road Investments Limited

+44 (0) 778 531 5588

John Croft

WH Ireland Limited - Nominated Adviser

+44 (0) 20 7220 1666

James Joyce

Andrew de Andrade

Hybridan LLP - Corporate Broker

+44 (0) 203 764 2341

Claire Noyce

Lionsgate Communications - Communications Adviser

+44 (0) 779 189 2509

Jonathan Charles

 

 

 

 

 

 

 

 

 

 

About Jade Road Investments

Jade Road Investments Limited is quoted on the AIM Market of the London Stock Exchange and is committed to providing shareholders with attractive uncorrelated, risk-adjusted long-term returns from a combination of realising sustainable capital growth and delivering dividend income.

 

The Company is focused on providing growth capital and financing to emerging and established Small and Medium Enterprises (SME) sector throughout Asia, and is well-diversified by national geographies, instruments and asset classes. This vital segment of the economy is underserved by the traditional banking industry for regulatory and structural reasons.

 

The Company's investment manager, Harmony Capital, seeks to capitalise on its team's established investment expertise and broad networks across Asia. Through rigorous diligence and disciplined risk management, Harmony Capital is dedicated to delivering attractive income and capital growth for shareholders with significant downside protection through selectively investing in assets and proactively managing them.

 

Harmony Capital is predominately sourcing private opportunities and continues to create a strong pipeline of attractive income-generating assets from potential investments in growth sectors across Asia, including healthcare, fintech, hospitality, IT and property. 

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZMGZMMKGZZM
Date   Source Headline
8th Jun 202611:31 amRNSVoting Results
22nd May 20262:50 pmRNSNew Investing Policy & Share Combination Circular
28th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSAppointments & Resignations of Non-exec Directors
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
18th Feb 20266:29 pmRNSHolding(s) in Company
11th Feb 20262:27 pmRNSCancellation of CLN subscription agreement
9th Feb 202611:00 amRNSRestoration - Jade Road Investments Limited
9th Feb 202611:00 amRNSEquity Subscription and Restoration of Trading
30th Jan 20267:00 amRNSEquity Subscription and Related Party Transaction
21st Jan 20265:57 pmRNSRe-denomination of trading currency
8th Jan 202612:06 pmRNSVoting Results
23rd Dec 20254:20 pmRNSConversion Notice
23rd Dec 20254:20 pmRNSConversion Notice
23rd Dec 20257:30 amRNSShare Combination Circular
23rd Dec 20257:30 amRNSShare Combination Circular
1st Dec 20257:00 amRNSProposed Fundraising and Suspension Update
17th Nov 20255:38 pmRNSAppointment of Nicolas Vassaux
3rd Nov 20255:28 pmRNSProposed Appointment of New Director
28th Oct 20252:09 pmRNSVoting Results
10th Oct 20257:00 amRNSWaiver of Takeover Provision, New Investing Policy
24th Sep 20254:46 pmRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2025
16th Sep 202512:15 pmRNSChange of Advisor
11th Sep 20251:05 pmRNSEquity Fundraising
3rd Jul 20251:09 pmRNSAnnual Financial Report
30th Jun 20255:57 pmRNSAnnual Results for 2024
29th May 20257:30 amRNSSuspension - Jade Road Investments Limited
29th May 20257:00 amRNSTemporary suspension of trading on AIM
27th May 20254:01 pmRNSSubscription Agreement
6th May 20253:00 pmRNSSubscription Update
28th Apr 20257:00 amRNSSubscription Agreement
11th Apr 202512:50 pmRNS2024 AGM Voting Results
1st Apr 20254:00 pmRNSTermination of investment with Woollard & Hall Ltd
20th Mar 20257:00 amRNSNotice of AGM, New Investing Policy & Share Reorg.
13th Mar 20257:45 amRNSTermination of Heirloom as Investment Manager
24th Feb 20257:00 amRNSProposed Change to Investing Policy
7th Feb 202512:45 pmRNSInvestment Commitment, Equity Fundraising and CLN
20th Nov 20243:11 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
25th Sep 20247:00 amRNSFurther tranche of convertible loan notes
18th Sep 20248:21 amRNSUpdate on strategic partnership with MBM Limited
16th Aug 20243:10 pmRNSStrategic partnership with MBM Limited
15th Jul 20247:00 amRNSChange of Nominated Adviser
11th Jul 20247:00 amRNSResignation of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.